451 related articles for article (PubMed ID: 19725237)
21. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.
Qudeimat MA; Barrieshi-Nusair KM; Owais AI
Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692
[TBL] [Abstract][Full Text] [Related]
22. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
Alqaderi HE; Al-Mutawa SA; Qudeimat MA
J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
[TBL] [Abstract][Full Text] [Related]
24. Pulp treatment for extensive decay in primary teeth.
Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
[TBL] [Abstract][Full Text] [Related]
25. Biodentine used as a pulp-capping agent in primary pig teeth.
Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV
Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156
[TBL] [Abstract][Full Text] [Related]
26. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
Frenkel G; Kaufman A; Ashkenazi M
J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
[TBL] [Abstract][Full Text] [Related]
27. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial.
Malekafzali B; Shekarchi F; Asgary S
Eur J Paediatr Dent; 2011 Sep; 12(3):189-93. PubMed ID: 22077689
[TBL] [Abstract][Full Text] [Related]
28. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
[TBL] [Abstract][Full Text] [Related]
29. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
Carti O; Oznurhan F
Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
[TBL] [Abstract][Full Text] [Related]
30. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA--a long term follow-up (84 months).
Cardoso-Silva C; Barbería E; Maroto M; García-Godoy F
J Dent; 2011 Feb; 39(2):187-93. PubMed ID: 21144878
[TBL] [Abstract][Full Text] [Related]
31. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
Juneja P; Kulkarni S
Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
[TBL] [Abstract][Full Text] [Related]
32. Vital pulp therapy with mineral trioxide aggregate.
Karabucak B; Li D; Lim J; Iqbal M
Dent Traumatol; 2005 Aug; 21(4):240-3. PubMed ID: 16026533
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
[TBL] [Abstract][Full Text] [Related]
34. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
Doyle TL; Casas MJ; Kenny DJ; Judd PL
Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
[TBL] [Abstract][Full Text] [Related]
35. Dentin bridge formation after white mineral trioxide aggregate (white MTA) pulpotomies in primary molars.
Maroto M; Barbería E; Vera V; García-Godoy F
Am J Dent; 2006 Apr; 19(2):75-9. PubMed ID: 16764128
[TBL] [Abstract][Full Text] [Related]
36. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis.
Asgary S; Shirvani A; Fazlyab M
J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717
[TBL] [Abstract][Full Text] [Related]
37. Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis.
Mettlach SE; Zealand CM; Botero TM; Boynton JR; Majewski RF; Hu JC
Pediatr Dent; 2013; 35(3):E87-94. PubMed ID: 23756301
[TBL] [Abstract][Full Text] [Related]
38. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.
Barrieshi-Nusair KM; Qudeimat MA
J Endod; 2006 Aug; 32(8):731-5. PubMed ID: 16861071
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
[TBL] [Abstract][Full Text] [Related]
40. Clinical and histological responses of human dental pulp to MTA and combined MTA/treated dentin matrix in partial pulpotomy.
Mehrvarzfar P; Abbott PV; Mashhadiabbas F; Vatanpour M; Tour Savadkouhi S
Aust Endod J; 2018 Apr; 44(1):46-53. PubMed ID: 28833942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
